Isolation Prevalence of Pulmonary Nontuberculous Mycobacteria in Ontario in 2007
Canadian Respiratory Journal, 2011 BACKGROUND: The reported prevalence of pulmonary nontuberculous mycobacteria (NTM) infections is increasing.
Mohammed Al Houqani +5 more
doaj +1 more source
Nontuberculous Mycobacteria, Botswana, 2011–2014
Emerging Infectious Diseases, 2019 We documented a 6-fold increase in the frequency of nontuberculous mycobacteria isolated from clinical samples in Botswana during 2011–2014. Because antituberculosis treatment is often initiated only on the basis of acid-fast bacilli smear-positive ...
Bontle Mbeha +3 more
doaj +1 more source
Clinical Case Reports, 2021 Rapidly growing nontuberculous mycobacteria should be considered if GPRs gram‐positive rods are detected in blood cultures 2‐3 days after the blood sample collection.
Tomoko Fujikawa +10 more
doaj +1 more source
Nontuberculous Mycobacteria-Overview
Microbiology Spectrum, 2017 ABSTRACT Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both immunocompromised and immunocompetent patients. The development of molecular methods has allowed the characterization of new species and the identification of NTM to the precise species and subspecies levels.
openaire +2 more sources
Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease [PDF]
, 2011 BACKGROUND: Mycobacterium malmoense is a nontuberculous mycobacteria seen mainly in two age groups and with different clinical presentations. Most patients are male adults presenting clinical symptoms and signs similar to those of pulmonary tuberculosis.
Barroso, L +7 more
core +1 more source
The Changing Pattern of Nontuberculous Mycobacterial Disease
Canadian Journal of Infectious Diseases, 2003 Nontuberculous mycobacteria are human opportunistic pathogens whose source of infection is the environment. These include both slow-growing (eg, Mycobacterium kansasii and Mycobacterium avium) and rapid-growing (eg, Mycobacterium abscessus and ...
Joseph O Falkinham
doaj +1 more source
In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria
Antimicrobial Agents and Chemotherapy, 2020 Infections caused by nontuberculous mycobacteria (NTM) are increasing globally. Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex are the most frequently encountered NTM, and oral treatment options are extremely limited for these ...
B. Brown-Elliott, R. Wallace
semanticscholar +1 more source
Lung organoids as a human system for Mycobacteria infection modeling and drug testing
The FEBS Journal, EarlyView.Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza +4 more
wiley +1 more source
Pseudo-outbreak of Mycobacterium gordonae in a teaching hospital: importance of strictly following decontamination procedures and emerging issues concerning sterilization [PDF]
, 2016 Aim of this study was to investigate a pseudo-outbreak of Mycobacterium gordonae analyzing isolates detected from clinical and environmental samples.
Alessia Cottarelli +10 more
core
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012 [PDF]
, 2016 BACKGROUND: The incidence of non-tuberculous mycobacteria (NTM) isolation from humans is increasing worldwide. In England, Wales and Northern Ireland (EW&NI) the reported rate of NTM more than doubled between 1996 and 2006.
H. Lucy Thomas +7 more
core +4 more sources